Justin Dye - Apr 6, 2022 Form 4 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Daniel R. Pabon Attorney-in-Fact for Justin Dye
Stock symbol: SHWZ
Transactions as of: Apr 6, 2022
Transactions value $: $140,108
Form type: 4
Date filed: 4/8/2022, 04:02 PM
Next filing: Feb 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SHWZ	Common Stock	Award	$138K	+67.4K	+83.82%	$2.05	148K	Apr 6, 2022	Direct	F1
transaction	SHWZ	Common Stock	Award	$2.03K	+1K	+0.68%	$2.03	149K	Apr 7, 2022	Direct
holding	SHWZ	Common Stock						9.29M	Apr 6, 2022	see footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.02 to $2.12 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Represents shares of common stock held by Dye Capital & Company ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

Content

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.02 to $2.12 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Represents shares of common stock held by Dye Capital & Company ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.